Manhattan Associates
MANH
202.11
-0.73
-0.36%
Manhattan Associates
US · MANH
#1334 by market cap
Listed 1970
202.11
-0.73
-0.36%
Live - 5344 symbols - heartbeat 112s ago
· 2026-10-08 08:39
Pre-market
202.01
-0.05%
After-hours
202.11
0.00%
- Market cap
- 11.78B
- P/E (TTM)i
- 57.91
- P/Bi
- 74.83
- EPSi
- 3.60
- Div yieldi
- 0.00%
- 52W posi
- 77%
Reader sentiment
Are you bullish or bearish on MANH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 16.63, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.75% YoY
Margins
- Gross margin
- 56.32%
- Operating margin
- 26.15%
- Net margin
- 20.34%
Key ratios & quality
- PEG ratioi
- 2.97
- Altman Z-Scorei
- 16.63
PEG uses trailing P/E against the 3-year net income growth rate (19.48%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 559.16M | 617.95M | 586.37M | 663.64M | 767.08M | 928.73M | 1.04B | 1.08B |
| Gross profit | 318.28M | 332.98M | 316.49M | 365.82M | 408.85M | 498.11M | 571.37M | 609.05M |
| Selling & admin expenses | 103.88M | 121.46M | 109.20M | 125.94M | 137.61M | 155.66M | 165.79M | 174.94M |
| Research & development | 71.90M | 87.61M | 84.28M | 97.63M | 111.88M | 126.81M | 137.69M | 145.06M |
| Operating profit | 133.89M | 115.92M | 114.06M | 134.33M | 152.70M | 209.88M | 261.60M | 282.74M |
| Pretax profit | 136.23M | 116.08M | 113.78M | 134.07M | 158.12M | 213.67M | 266.81M | 285.89M |
| Tax | 31.54M | 30.32M | 26.54M | 23.60M | 29.16M | 37.10M | 48.45M | 65.95M |
| Net profit | 104.69M | 85.76M | 87.24M | 110.47M | 128.96M | 176.57M | 218.36M | 219.95M |
| Basic EPS | 2 | 1 | 1 | 2 | 2 | 3 | 4 | 4 |
| Diluted EPS | 1.58 | 1.32 | 1.36 | 1.72 | 2.03 | 2.82 | 3.51 | 3.60 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 262.79M | 272.42M | 275.80M | 270.39M | 282.22M | 297.79M |
| Gross profit | 148.22M | 156.21M | 155.98M | 148.64M | 155.57M | 168.33M |
| Selling & admin expenses | 45.28M | 45.96M | 42.14M | 41.57M | 51.46M | 57.44M |
| Research & development | 35.30M | 34.87M | 36.36M | 38.53M | 37.35M | 34.77M |
| Operating profit | 66.10M | 73.80M | 75.83M | 67.01M | 64.94M | 74.49M |
| Pretax profit | 64.51M | 74.50M | 78.43M | 68.45M | 69.27M | 67.21M |
| Tax | 11.93M | 17.72M | 19.80M | 16.50M | 19.98M | 16.86M |
| Net profit | 52.58M | 56.78M | 58.63M | 51.95M | 49.30M | 50.35M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.85 | 0.93 | 0.96 | 0.86 | 0.82 | 0.85 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 215.38M | 232.04M | 334.04M | 408.42M | 415.38M | 479.19M | 503.26M | 583.34M |
| Cash & ST investments | 100.57M | 110.68M | 204.71M | 263.71M | 225.46M | 270.74M | 266.23M | 328.75M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 307.15M | 372.28M | 465.41M | 539.71M | 570.18M | 673.35M | 757.55M | 839.39M |
| Total current liabilities | 145.26M | 181.60M | 196.99M | 249.04M | 315.60M | 365.92M | 400.30M | 455.91M |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 160,003,000.00 | 230,001,000.00 | 246,515,000.00 | 289,064,000.00 | 343,378,000.00 | 395,075,000.00 | 458,425,000.00 | 524,623,000.00 |
| Total equity | 147.15M | 142.28M | 218.90M | 250.64M | 226.80M | 278.28M | 299.13M | 314.77M |
| Retained earnings | 163.36M | 159.49M | 236.52M | 269.84M | 253.71M | 304.70M | 329.44M | 345.10M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 455.34M | 483.35M | 525.77M | 583.34M | 515.82M | 467.06M |
| Cash & ST investments | 205.87M | 230.59M | 263.56M | 328.75M | 226.13M | 186.11M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 708.22M | 744.68M | 768.82M | 839.39M | 740.54M | 698.65M |
| Total current liabilities | 405.02M | 407.17M | 400.41M | 455.91M | 467.40M | 475.05M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 463,126,000.00 | 465,925,000.00 | 459,607,000.00 | 524,623,000.00 | 535,363,000.00 | 541,139,000.00 |
| Total equity | 245.10M | 278.76M | 309.22M | 314.77M | 205.18M | 157.51M |
| Retained earnings | 274.08M | 304.48M | 338.69M | 345.10M | 240.58M | 193.95M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 137.35M | 146.91M | 140.89M | 185.18M | 179.63M | 246.22M | 295.00M | 389.47M |
| Depreciation & amortization | 8.61M | 7.99M | 8.95M | 7.91M | 6.66M | 5.75M | 6.30M | 6.32M |
| Free cash flow | 130.04M | 131.72M | 138.16M | 181.17M | 173.04M | 241.49M | 286.33M | 374.01M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -149.32M | -121.49M | -43.56M | -120.42M | -204.46M | -196.05M | -286.37M | -315.16M |
| Ending cash balance | 99.13M | 110.68M | 204.71M | 263.71M | 225.46M | 270.74M | 266.23M | 328.75M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 75.26M | 74.05M | 93.11M | 147.05M | 84.05M | 90.68M |
| Depreciation & amortization | 1.54M | 1.58M | 1.66M | 1.53M | 1.83M | 1.63M |
| Free cash flow | 74.37M | 70.07M | 87.18M | 142.39M | 79.94M | 89.68M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -136.45M | -50.19M | -51.55M | -76.98M | -179.39M | -127.09M |
| Ending cash balance | 205.87M | 230.59M | 263.56M | 328.75M | 226.13M | 186.11M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 65.00 | 59.26 | 48.31 | 47.06 | 54.02 | 69.92 | 75.64 | 71.66 |
| ROA %i | 33.65 | 25.25 | 20.83 | 21.98 | 23.24 | 28.40 | 30.52 | 27.55 |
| ROIC %i | 64.50 | 48.12 | 41.37 | 42.42 | 49.92 | 64.15 | 66.40 | 60.34 |
| 5-year avg ROE %i | 60.14 | 62.97 | 61.67 | 57.46 | 54.73 | 55.71 | 58.99 | 63.66 |
| EBIT margin %i | 23.94 | 18.76 | 19.45 | 20.24 | 19.91 | 22.60 | 25.10 | 26.15 |
| FCF / sales %i | 23.26 | 21.31 | 23.56 | 27.30 | 22.56 | 26.00 | 27.47 | 34.59 |
| Current ratioi | 1.48 | 1.28 | 1.70 | 1.64 | 1.32 | 1.31 | 1.26 | 1.28 |
| Quick ratioi | 1.39 | 1.17 | 1.60 | 1.57 | 1.24 | 1.24 | 1.19 | 1.21 |
| Debt / assetsi | 0.00 | 8.71 | 5.98 | 4.29 | 2.47 | 2.63 | 6.31 | 6.69 |
| LT debt / equityi | -- | 22.78 | 12.72 | 9.24 | 6.20 | 6.36 | 15.98 | 17.85 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 0.17 | 0.73 | -0.46 | 5.88 | 7.47 | 16.57 | 16.24 | 12.13 |
| Net income CAGR (3Y) %i | 0.39 | -11.62 | -9.19 | 1.81 | 14.57 | 26.49 | 25.50 | 19.48 |
| FCF CAGR (3Y) %i | 6.17 | -0.20 | -4.35 | 11.69 | 9.52 | 20.46 | 16.48 | 29.29 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 89.60 | 85.16 | 73.58 | 71.66 | 96.24 | 96.38 |
| ROA %i | 31.40 | 31.37 | 29.45 | 27.55 | 29.91 | 29.13 |
| ROIC %i | 74.43 | 71.48 | 63.08 | 60.34 | 78.36 | 76.91 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 25.71 | 26.06 | 25.91 | 26.15 | 25.58 | 25.06 |
| FCF / sales %i | 29.34 | 29.05 | 31.23 | 34.59 | 34.48 | 35.45 |
| Current ratioi | 1.12 | 1.19 | 1.31 | 1.28 | 1.10 | 0.98 |
| Quick ratioi | 1.03 | 1.08 | 1.21 | 1.21 | 0.97 | 0.85 |
| Debt / assetsi | 6.64 | 6.52 | 6.21 | 6.69 | 7.52 | 7.71 |
| LT debt / equityi | 19.18 | 17.43 | 15.43 | 17.85 | 27.14 | 34.21 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 08:39:35 · For reference only, not investment advice and not tailored to your situation.